| View this message online 
Hello manoj kumar valluru, Last week Medistem announced filing of an IND for use of their new endometrial regenerative cells (ERC) for treatment of critical limb ischemia. A very interesting patent #7,468,193 was issued covering a nutritional mix containing TGF-beta for cancer patients being treated with chemotherapy and/or radiation...ever wonder what a cytokine tastes like? Bob Hariri continued his patenting of placental derived regenerative cells, #7,468,276 being the latest to the collection, claiming intra alia Oct4+, CD34- pluripotent cells from this source. A new method for isolating neural progenitor preparations isolated from fetal brains that doesn't depend on CD133 selection was described in #7,468,277. Happy Holidays !!!!!!!!!!! | | Patent Number: 7,468,193 We at StemCellPatents.com have been seeing an increasing interest in "nutritional" modulation of the stem cell compartment. For example, patent # 7,338,676 teaches the use pine cone extracts for inducing differentiation of progenitor cells to dendritic cells. Patent # [Read More] Ask a question OR leave your comments. | | |
The 3rd Annual Stem Cells World Congress (20-22 January 2009)
The Stem Cell Meeting (March 2009)
| | NEWS - WHAT'S GETTING ATTENTION? | | |
Thanks again for your help in supporting StemCellPatents.com.
NEW -  (BETA) Now you can send our newsletters to your friends and colleagues using our quick and easy send-to-a-friend feature (BETA).
------------------------------------------------------------ To unsubscribe, click here. Delivered: Monday December 29th, 2008 @ 14:30:07 EST | 
